Mars Group Holdings Corporation (TYO:6419)

Orchard Therapeutics Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	35,469	36,373	29,353	22,700	26,003	23,228
Short-Term Investments	350.54	350	350	349	349	349
Cash & Short-Term Investments	35,820	36,723	29,703	23,049	26,352	23,577
Cash Growth	20.93%	23.63%	28.87%	-12.53%	11.77%	3.77%
Receivables	4,957	5,488	7,193	5,597	4,464	5,651
Inventory	8,659	8,919	11,608	5,604	2,810	2,782
Other Current Assets	1,956	874	744	872	344	696
Total Current Assets	51,392	52,004	49,248	35,122	33,970	32,706
Property, Plant & Equipment	16,728	16,272	16,088	15,164	14,439	13,040
Long-Term Investments	16,752	18,252	18,296	12,884	10,535	10,851
Other Intangible Assets	502.89	470	323	306	322	275
Long-Term Deferred Tax Assets	-	-	-	445	866	1,088
Other Long-Term Assets	1,897	2	1	1	3	1
Total Assets	87,272	87,000	83,956	63,922	60,135	57,961
Accounts Payable	2,299	1,627	4,338	2,858	1,321	1,166
Accrued Expenses	246.28	490	431	342	278	345
Current Portion of Leases	185.01	182	240	268	332	459
Current Income Taxes Payable	778.04	1,783	3,667	1,052	841	241
Other Current Liabilities	1,532	1,914	1,651	947	871	1,016
Total Current Liabilities	5,040	5,996	10,327	5,467	3,643	3,227
Long-Term Leases	380.1	362	288	294	474	640
Long-Term Deferred Tax Liabilities	-	897	858	-	-	-
Other Long-Term Liabilities	2,246	1,028	1,036	1,093	1,128	1,094
Total Liabilities	8,172	8,771	12,704	7,616	5,894	5,664
Common Stock	7,934	7,934	7,934	7,934	7,934	7,934
Additional Paid-In Capital	10,287	10,286	9,500	8,371	8,371	8,371
Retained Earnings	63,561	62,991	58,102	51,144	49,237	48,647
Treasury Stock	-8,514	-8,513	-9,584	-12,655	-12,006	-12,315
Comprehensive Income & Other	5,832	5,531	5,300	1,512	705	-340
Shareholders' Equity	79,100	78,229	71,252	56,306	54,241	52,297
Total Liabilities & Equity	87,272	87,000	83,956	63,922	60,135	57,961
Total Debt	565.11	544	528	562	806	1,099
Net Cash (Debt)	35,255	36,179	29,175	22,487	25,546	22,478
Net Cash Growth	21.10%	24.01%	29.74%	-11.97%	13.65%	4.81%
Net Cash Per Share	1911.60	1974.67	1689.13	1359.79	1517.86	1345.99
Filing Date Shares Outstanding	18.44	18.44	18.16	16.42	16.84	16.7
Total Common Shares Outstanding	18.44	18.44	17.92	16.42	16.84	16.7
Working Capital	46,352	46,008	38,921	29,655	30,327	29,479
Book Value Per Share	4289.01	4241.76	3976.18	3429.29	3221.20	3131.56
Tangible Book Value	78,597	77,759	70,929	56,000	53,919	52,022
Tangible Book Value Per Share	4261.74	4216.27	3958.16	3410.65	3202.07	3115.09

Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.